Skip to main content

Erica F. Andersen, Ph.D., FACMG

Languages spoken: English, Spanish

Academic Information

Departments: Pathology - Associate Professor (Clinical)

Divisions: Clinical Pathology

Academic Office Information

erica.andersen@path.utah.edu

Board Certification

  • American Board of Medical Genetics (Clinical Cytogenetics)
  • American Board of Medical Genetics and Genomics (Laboratory Genetics and Genomics)

Research Interests

  • Cytogenetics
  • Genomics
  • Constitutional and Acquired Genetic Abnormalities
  • Heritable Genetic Conditions
  • Hematologic Neoplasms

Erica Andersen is an Associate Professor of Pathology at the University of Utah and Section Chief of the Cytogenetics and Genomic Microarray Laboratories at ARUP Laboratories in Salt Lake City, Utah. She received a PhD in Genetics from the University of Wisconsin-Madison and completed a Clinical Cytogenetics fellowship at ARUP Laboratories and the University of Utah. She is board certified by the American Board of Medical Genetics and Genomics and is a fellow of the American College of Medical Genetics and Genomics. Dr. Andersen's research and professional interests include improving diagnostic and interpretative tools for cytogenetic and genomic testing, including copy number variant interpretation. She is an active member of the Clinical Genome Resource (ClinGen) and has published novel genetic findings in hereditary disease and in rare hematologic and lymphoid tumors.

Research Statement

Erica Andersen is an Associate Professor of Pathology at the University of Utah and Section Chief of the Cytogenetics and Genomic Microarray Laboratories at ARUP Laboratories in Salt Lake City, Utah. She received a PhD in Genetics from the University of Wisconsin-Madison and completed a Clinical Cytogenetics fellowship at ARUP Laboratories and the University of Utah. She is board certified by the American Board of Medical Genetics and Genomics and is a fellow of the American College of Medical Genetics and Genomics. Dr. Andersen's research interests span both heritable and acquired genetic diseases. She has published novel genetic findings in association with developmental disorders and is an active member of the Clinical Genome Resource (ClinGen) group's efforts to improve constitutional copy number variant interpretation in the clinical setting. Her genetic oncology research projects include improving the diagnosis and monitoring for hematologic disease and understanding the genetic etiology of rare hematologic tumors, including histiocytic and dendritic cell neoplasms.

Education History

Fellowship University of Utah and ARUP Laboratories
Clinical Cytogenetics
Fellow
Doctoral Training University of Wisconsin-Madison
Genetics
Ph.D.
Undergraduate Macalester College
Major: Biology-Genetics, Cell Biology, and Development; Core/Minor: Chemistry
B.A.